Culleton Bruce's most recent trade in ProKidney Corp - Ordinary Shares - Class A was a trade of 1,796,000 Employee stock option (right to buy) done . Disclosure was reported to the exchange on March 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProKidney Corp - Ordinary ... | Bruce Culleton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 1,796,000 | 1,796,000 | - | - | Employee stock option (right to buy) | |
| ProKidney Corp - Ordinary ... | Bruce Culleton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2024 | 500,000 | 500,000 | - | - | Employee stock option (right to buy) | |
| ProKidney Corp - Ordinary ... | Culleton Bruce | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2023 | 2,000,000 | 2,000,000 | - | - | Employee stock option (right to buy) | |
| ProKidney Corp - Ordinary ... | Bruce Culleton | EVP, Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 485,000 | 485,000 | - | - | Employee stock option (right to buy) |